Positioning political selling, disclosed 2026-08-05
Options no verdict drawn today, left as found
Ethical does not pass the values gate
Price22.93 USD
Fair value36.74
Ethical score10.0/100
RatingAVOID
Our investment reviews on this name
2026-08-24Read Markup26.42-13.2% to today
2026-07-03Read Markdown23.82-3.7% to today ✓
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Comcast holds its Distribution at $22.93. The statistical read favours the sellers, held for 6 days.
As held on the ledger · 2026-09-21
Phase
Distribution · caution
Quantitative state
The statistical read favours the sellers, held for 6 days
Price at the screen
$22.93
Valuation
7.35 trailing · 6.33 forward price to earnings
Values screen
FAIL· score 10.0
Beta
0.66
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
36.29%
Below 33%
Interest-bearing debt is 36.3% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
2.92%
Below 33%
Cash held in interest-bearing accounts and securities is 2.9% of assets, under the one-third limit.
Pass
Receivables
8.56%
Below 49%
Money owed to the company is 8.6% of assets, under the 49% limit.
Pass
Revenue purity
0.00%
Below 5%
Only 0.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is Worth
The Fair Value Range
Our framework reads AVOID: it trades at roughly a 60% discount to our $36.74 fair value, moderate competitive moat.
Fair value range in USD, drawn from the 2026-09-21 screen. The gold marker is the market price at the same screen. A 60.2% margin of safety to the base estimate.
Third-party analyst targets: 22 covering, consensus None. The average target sits +28% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-21 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Comcast pipes the bills but carries too much debt
Comcast pipes internet and shows into homes across America, yet the balance sheet carries more debt than we can stomach. We are staying away, for one clear reason that has nothing to do with subscriber numbers or theme parks. The ethical screen flags the debt ratio straight away. This is exactly what the screen is for.
The shares trade at 6.4 times forward earnings with revenue growing 5 percent and a 15 percent profit margin, yet that leverage outweighs the 21 percent ROE and moderate moat in our view. Twenty one analysts sit on hold with a median target of 31 dollars, well below our own fair value.
Risk sits in rising interest costs on the debt pile and any slowdown in broadband adds or studio releases that could crimp the cash flow. Analysis, not advice.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
CMCSA trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-08-24Markup · changed$26.42+11.1%Entry 11
The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 11.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it hold, with a mean price target of $33.
2026-07-23Markdown$23.79+0.0%Entry 10
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it hold, with a mean price target of $33. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-22Markdown$23.79+0.0%Entry 9
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it hold, with a mean price target of $33. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-21Markdown$23.79+0.0%Entry 8
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it hold, with a mean price target of $33. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-20Markdown$23.79+0.0%Entry 7
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it hold, with a mean price target of $33. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-19Markdown$23.79-0.1%Entry 6
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it hold, with a mean price target of $33. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-18Markdown$23.82+0.0%Entry 5
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it hold, with a mean price target of $33. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-17Markdown$23.82+0.0%Entry 4
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it hold, with a mean price target of $33. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-16Markdown$23.82+0.0%Entry 3
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it hold, with a mean price target of $33. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-03Markdown$23.82+0.0%Entry 2
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
